Oran Erster Selected Research

Oran Erster Research Topics

7	COVID-19 01/2023 - 01/2021
6	Infections 01/2023 - 02/2016
2	Poliomyelitis (Polio) 05/2023 - 01/2022
2	Lumpy Skin Disease 06/2016 - 01/2016
1	Chronic Hepatitis B 11/2022
1	Asymptomatic Infections 01/2020
1	Acute Disease 01/2020
1	Atherosclerotic Plaque (Atheroma) 08/2012

6	VaccinesIBA 05/2023 - 01/2016
2	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2016
2	BNT162 VaccineIBA 01/2022 - 12/2021
2	Neutralizing AntibodiesIBA 12/2021 - 01/2021
2	WastewaterIBA 11/2021 - 01/2021
2	Lysergic Acid Diethylamide (LSD)IBA 06/2016 - 01/2016
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Liposomes (Liposome)IBA 01/2023
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2022
1	Ivermectin (Mectizan)FDA Link 09/2022
1	Saline SolutionIBA 10/2021
1	BuffersIBA 01/2021
1	AntigensIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	SolutionsIBA 01/2021
1	Viral RNAIBA 01/2020
1	Immunoglobulin A (IgA)IBA 01/2020
1	AntibodiesIBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	EpitopesIBA 09/2019
1	4-O-carboxymethylascochlorinIBA 02/2016
1	Matrix Metalloproteinases (MMPs)IBA 08/2012
1	Metalloproteases (Metalloproteinases)IBA 08/2012
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 08/2012
1	Peptide Hydrolases (Proteases)FDA Link 08/2012
1	Peptides (Polypeptides)IBA 08/2012